Home/Filings/4/0001062993-22-021772
4//SEC Filing

McCourt Janice 4

Accession 0001062993-22-021772

CIK 0001907685other

Filed

Nov 8, 7:00 PM ET

Accepted

Nov 9, 4:19 PM ET

Size

5.3 KB

Accession

0001062993-22-021772

Insider Transaction Report

Form 4
Period: 2022-11-08
McCourt Janice
Chief Business Officer
Transactions
  • Award

    Stock Option (Right to Purchase)

    2022-11-08+150,000150,000 total
    Exercise: $1.36Exp: 2032-11-08Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]The stock option shall vest over four (4) years, with twenty-five percent (25%) of the shares of Common Stock underlying the option vesting on November 1, 2023 and the remainder vesting in equal monthly installments thereafter.

Issuer

Comera Life Sciences Holdings, Inc.

CIK 0001907685

Entity typeother

Related Parties

1
  • filerCIK 0001953540

Filing Metadata

Form type
4
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 4:19 PM ET
Size
5.3 KB